Changqing Ye
CIK: 0001968607
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Oct 19, 2026NIU
Niu Technologies
Exercise(M)Direct20K shares- - Oct 19, 2026NIU
Niu Technologies
Award(A)DirectRestricted share units
80K shares- - Jun 30, 2026BZUN
Baozun Inc.
Exercise(M)Direct17.3K shares- - May 21, 2026BZUN
Baozun Inc.
Award(A)DirectRestricted Stock Unit
42K shares-
1-4 of 4 transactions
About Ye Changqing
Ye Changqing (SEC CIK 0001968607) files insider reports with the SEC as Director of Niu Technologies (NIU), Director of Baozun Inc. (BZUN) and Director of ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG).
Signal8 holds 7 ownership filings by Ye Changqing (4 Form 3, 3 Form 4), filed between Mar 4, 2026 and Oct 20, 2026. Those filings report 4 transactions, from May 21, 2026 to Oct 19, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Ye Changqing's filings is in HONG KONG.
Recent filings by Ye Changqing
Other insiders filing for Niu Technologies (NIU)
- CHENG MEI WEI, Director
- Zhang Jinshu, Director
- Zhou Fion Wenjuan, Chief Financial Officer
- Li Yan, Chief Executive Officer